Research & Development

Research Reveals Inaccuracies in Common Gene Therapy Measurement Methods
Research & Development Research Reveals Inaccuracies in Common Gene Therapy Measurement Methods

Gene therapy, a revolutionary approach to treating and preventing diseases by modifying faulty genes, relies heavily on accurate measurement techniques. Ensuring the safety and efficacy of these treatments necessitates precise quantification of adeno-associated virus (AAV) vectors, which deliver

DARPA Funds OSU's $11.9M Nanotech Project for Military Health Protection
Research & Development DARPA Funds OSU's $11.9M Nanotech Project for Military Health Protection

The U.S. Department of Defense has awarded a substantial grant of $11.9 million to the Oregon State University (OSU) College of Pharmacy, with the aim of developing advanced drug delivery technologies specifically designed to protect military personnel from various health threats encountered in

How Will UQ and Vaxxas' Patch Revolutionize COVID-19 mRNA Vaccines?
Research & Development How Will UQ and Vaxxas' Patch Revolutionize COVID-19 mRNA Vaccines?

Imagine a world where getting vaccinated no longer means facing a needle and syringe, but instead, involves a simple patch applied to the skin. This prospect is rapidly becoming a reality thanks to the innovative work of the University of Queensland (UQ) and Brisbane-based biotech company Vaxxas.

Are Aneuploid Cells in Healthy Breast Tissue Linked to Cancer Risk?
Research & Development Are Aneuploid Cells in Healthy Breast Tissue Linked to Cancer Risk?

Aneuploidy, the presence of an abnormal number of chromosomes within a cell, is widely recognized as a defining hallmark of cancer. This association has guided cancer diagnostics and research for years, embedding in the scientific community's understanding of how cancers develop and progress.

Can Nasal-Brain Delivery Revolutionize Glioblastoma Treatment?
Research & Development Can Nasal-Brain Delivery Revolutionize Glioblastoma Treatment?

Glioblastoma multiforme, an aggressive form of brain cancer, has long been a formidable challenge in the medical field. With patient survival rates stagnating around 15 to 18 months, the need for innovative treatment approaches is critical. NeOnc Technologies, under the leadership of Dr. Thomas

Adicet Bio Advances ADI-001 CAR T-Cell Therapy for Autoimmune Diseases
Research & Development Adicet Bio Advances ADI-001 CAR T-Cell Therapy for Autoimmune Diseases

Adicet Bio is pioneering significant developments in its innovative CAR T-cell therapy, ADI-001, aimed at treating a range of autoimmune diseases. Among the targeted conditions are ANCA-associated vasculitis (AAV), systemic lupus erythematosus (SLE), and systemic sclerosis. Initially, patient

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later